| No surgical innovation without evaluation: the IDEAL recommendations. McCulloch P Lancet 374 (9695), 1105-12, 2009 | 1742 | 2009 |
| Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial S Kehoe, J Hook, M Nankivell, GC Jayson, H Kitchener, T Lopes, ... The Lancet 386 (9990), 249-257, 2015 | 1269 | 2015 |
| Revised FIGO staging for carcinoma of the cervix uteri N Bhatla, JS Berek, M Cuello Fredes, LA Denny, S Grenman, ... International Journal of Gynecology & Obstetrics 145 (1), 129-135, 2019 | 815 | 2019 |
| The hypercoagulable state of malignancy: pathogenesis and current debate GJ Caine, PS Stonelake, GYH Lip, ST Kehoe Neoplasia (New York, NY) 4 (6), 465, 2002 | 687 | 2002 |
| CHALLENGES IN EVALUATING SURGICAL INNOVATION. BJM Ergina PL, Cook JA Lancet 374, 1097-104, 2009 | 661 | 2009 |
| Evaluation and stages of surgical innovations JS Barkun, JK Aronson, LS Feldman, GJ Maddern, SM Strasberg The Lancet 374 (9695), 1089-1096, 2009 | 601 | 2009 |
| Lymphadenectomy for the management of endometrial cancer JA Frost, KE Webster, A Bryant, J Morrison Cochrane Database of Systematic Reviews, 2017 | 360 | 2017 |
| Lymphadenectomy for the management of endometrial cancer K May, A Bryant, HO Dickinson, S Kehoe, J Morrison Cochrane database of systematic reviews, 2010 | 300 | 2010 |
| Cancer of the ovary, fallopian tube, and peritoneum JS Berek, ST Kehoe, L Kumar, M Friedlander International journal of gynecology & obstetrics 143, 59-78, 2018 | 295 | 2018 |
| Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer J Morrison, K Haldar, S Kehoe, TA Lawrie Cochrane Database of Systematic Reviews, 2012 | 242 | 2012 |
| Symptoms associated with diagnosis of ovarian cancer: a systematic review CR Bankhead, ST Kehoe, J Austoker BJOG: An International Journal of Obstetrics & Gynaecology 112 (7), 857-865, 2005 | 239 | 2005 |
| Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials I Vergote, C Coens, M Nankivell, GB Kristensen, MKB Parmar, T Ehlen, ... The Lancet Oncology 19 (12), 1680-1687, 2018 | 227 | 2018 |
| The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma S Kehoe, J Powell, S Wilson, C Woodman British journal of cancer 70 (5), 1014-1017, 1994 | 217 | 1994 |
| The TNM classification of malignant tumours—towards common understanding and reasonable expectations B O'Sullivan, J Brierley, D Byrd, F Bosman, S Kehoe, C Kossary, ... The Lancet Oncology 18 (7), 849-851, 2017 | 196 | 2017 |
| Identifying symptoms of ovarian cancer: a qualitative and quantitative study CR Bankhead, C Collins, H Stokes‐Lampard, P Rose, S Wilson, ... BJOG: An International Journal of Obstetrics & Gynaecology 115 (8), 1008-1014, 2008 | 195 | 2008 |
| Ovarian tumours in pregnancy: a literature review P Aggarwal, S Kehoe European Journal of Obstetrics & Gynecology and Reproductive Biology 155 (2 …, 2011 | 182 | 2011 |
| Adrenomedullin and tumour angiogenesis LL Nikitenko, SB Fox, S Kehoe, MCP Rees, R Bicknell British journal of cancer 94 (1), 1-7, 2006 | 172 | 2006 |
| Cancer of the ovary, fallopian tube, and peritoneum: 2021 update JS Berek, M Renz, S Kehoe, L Kumar, M Friedlander International Journal of Gynecology & Obstetrics 155, 61-85, 2021 | 156 | 2021 |
| Aggressive angiomyxoma: a case series and literature review K Haldar, IE Martinek, S Kehoe European Journal of Surgical Oncology (EJSO) 36 (4), 335-339, 2010 | 146 | 2010 |
| Diagnosis of ovarian cancer S Sundar, RD Neal, S Kehoe Bmj 351, 2015 | 123 | 2015 |
